global rivastigmine market in 2017. This is owing to increasing prevalence of chronic kidney
disease in the region that may lead to dementia. According to The American Kidney Fund, around
31 million people suffered from chronic kidney disease in 2015. Europe accounted for the second
largest share in terms of revenue in the global rivastigmine market, in 2017 owing to increasing
geriatric population in the region. Geriatric population is more prone to dementia. According to
World Population Prospects (WPP), in 2017, around 25% of the population in Europe was aged 60
years or above. According to the Alzheimer’s Association, in 2017, there was significant prevalence
of vascular diseases in Latin America and Africa. Therefore, Latin America and Africa are expected
to witness significant growth in the global rivastigmine market during the forecast period.
For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/rivastigmine-market-2407
Rivastigmine Market – Competitive Landscape
Major players operating in the global rivastigmine market include, Novartis Europharm Limited,
Actavis Pharma, Apotex Corporation, Aurobindo Pharm Ltd, Teva Pharmaceuticals Industries Ltd,
Dr. Reddy’s Laboratories, Macleods, and others. Key players in the market are focused on product
development and approvals in order to enhance their market share. For instance, in 2007, U.S. FDA
approved Exelon (Rivastigmine tartarate) — developed by Novartis Europharm Limited for the
treatment of Alzheimer's and Parkinson's disease.
Global Rivastigmine Market Taxonomy:
On the basis of disease indication, the global rivastigmine market is segmented into:
•Alzheimer’s disease
•Parkinson’s disease
On the basis of formulation, the global rivastigmine market is segmented into:
•Capsules
•Transdermal Patches
On the basis of distribution channel, the global rivastigmine market is segmented into:
•Hospital pharmacies
•Retail pharmacies
•Online pharmacies
On the basis of geography, the global rivastigmine market is segmented into:
•North America
•Latin America
•Europe
•Asia Pacific
•Middle East
•Africa
Request For Customization @ https://www.coherentmarketinsights.com/insight/request-
customization/2407